EMINENCE CAPITAL, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
EMINENCE CAPITAL, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$84,445,000
+153.3%
847,328
+192.0%
0.92%
+146.4%
Q4 2019$33,337,000
-11.5%
290,140
-2.9%
0.38%
-17.4%
Q3 2019$37,679,000
-64.4%
298,706
-66.1%
0.45%
-67.5%
Q2 2019$105,926,000
+987.4%
880,219
+690.5%
1.40%
+864.1%
Q1 2019$9,741,000111,3560.14%
Other shareholders
HAEMONETICS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders